Fundraising Fox

BioIntelliSense

Delaware corporation · 4 known investors

biointellisense.com ↗

BioIntelliSense develops a wearable device and software platform for continuous monitoring of patient vital signs and biometric data in hospital and home settings. The system uses exception management workflows to detect early indicators of clinical deterioration and enable proactive interventions.

HealthtechIoTMedical Devicesin /biointellisense

Founders & leadership

CM
Conlan MaDirector
DW
David WangExecutive Officer, Director
XY
Xinyaun YuDirector
JM
James MaultExecutive Officer, Director
RC
Ronald ChwangDirector
AM
Alan MeekerDirector
LL
Larry LeisureDirector
SH
Steve HessDirector

Investors · 4

Bose VenturesBoston
CU Healthcare Innovation FundAurora
Fresenius Medical Care VenturesBad Homburg
SkyPoint VenturesFlintvia Phil Hagerman · inferred

Reported raises · per SEC filings

Form D private placements
▶$58.3MraisedJun 2026 · 14 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Conlan MaDirector
  • David WangExecutive Officer, Director
  • Xinyaun YuDirector
  • James MaultExecutive Officer, Director
Offering amount
$58.4M
Amount sold
$58.3M
First sale
Dec 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$45MraisedSep 2022 · 16 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • David WangExecutive Officer
  • Alan MeekerDirector
  • James R. MaultExecutive Officer, Director
  • John DriscollDirector
  • Lawrence LeisureDirector
  • Steve HessDirector
Offering amount
$45M
Amount sold
$45M
First sale
Apr 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$25MraisedSep 2020 · 22 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Steve HessDirector
  • Alan MeekerDirector
  • Larry LeisureDirector
  • Ronald ChwangDirector
  • James MaultExecutive Officer, Director
Offering amount
$25M
Amount sold
$25M
First sale
Dec 2018
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12MraisedSep 2020 · 11 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • James MaultExecutive Officer, Director
  • Ronald ChwangDirector
  • Alan MeekerDirector
  • Larry LeisureDirector
  • Steve HessDirector
Offering amount
$12M
Amount sold
$12M
First sale
Aug 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.